We helped Medical Development International move into the European market by creating a new, scalable and reliable manufacturing process for their Penthrox 'green whistle' pain-relieving drug.
Delivering pain relief
Medical Developments International (MDI) is an Australian company that manufactures Penthrox, commonly known as the 'green whistle'.
Penthrox is an analgesic used by medical practitioners, the defence forces, ambulance paramedics, sports clubs and surf lifesavers to administer emergency pain relief. It's non-addictive and simple to administer, making it an excellent choice for situations where fast-acting and uncomplicated relief is needed.
With plans to export overseas, MDI needed a smarter, more efficient and cost-effective way to manufacture Methoxyflurane.
Reducing costs and upscaling production
We have been working with MDI for more than 18 years. Having developed the initial production process for Penthrox together, we've now vastly improved it.
In a technology deal, we invested $750,000 in order to significantly reduce the cost of producing Penthrox and facilitate large-scale production.
Together, we came up with a smart, efficient manufacturing process that significantly reduces the cost of producing Methoxyflurane while providing a more consistent result.
Reaching new markets
MDI's market value has risen from less than $10 million dollars in March 2010 to around $517 million today.
Collaboration with CSIRO has given MDI the capacity to enter new export markets and confidence their supply can match demand.
Penthrox has now been approved for sale in 27 European countries plus the UAE, Hong Kong, Saudi Arabia, Jordan, Taiwan and Mexico. MDI has regulatory approval in Canada. The product approval process is also underway in the USA Iran, Iraq, South Korea and Russia.
New production facility
MDI built a new Melbourne facility to cope with global demand for Penthrox.
It's specifically designed around the CSIRO manufacturing process and allows MDI to increase production as exports grow.
Twenty-six new jobs have already been created and MDI's workforce is expected to double in coming years.
The new facility takes in more than 1000 square metres of processing machinery, bottling, labelling and assembly, as well as research and development labs.
There's also plenty of room left to grow as MDI does.